• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG SHUNTASSISTANT 20; HYDROCEPHALUS VALVES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG SHUNTASSISTANT 20; HYDROCEPHALUS VALVES Back to Search Results
Model Number FV424T
Device Problem Obstruction of Flow (2423)
Patient Problem Failure of Implant (1924)
Event Date 10/16/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).(b)(6).When additional information is received a follow up report will be submitted.
 
Event Description
It was reported by the healthcare professional "5y 7m po over drainage of the valve.Explanted." all med watch submissions related to this patient are: 3004721439-2018-00272, 3004721439-2018-00273 (this report).
 
Manufacturer Narrative
Investigation: visual inspection: a deformation of the outer housing of the progav was observed through the visual inspection.The progav housing was subsequently measured and the presence of a deformation was confirmed.The housing deformation measured at -0.0510mm, outside the tolerance of 0 +/- 0.02mm.Permeability test: a permeability test has shown that the progav is permeable, although slower draining than expected.Adjustment test: the progav was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Computer controlled test: to test the opening pressure, we use a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The progav is not operating within acceptable tolerances.The opening pressure is higher than expected.Results: finally, we have dismantled the valve.Inside the valve we have found minimal evidence of deposits of substances (likely protein).Based on out investigation, we are unable to substantiate the claim of over-drainage.Conversely, we have determined that the valve is operating in a state of under-drainage and showing signs of blockage.This is likely due to the build-up observed inside the valve.Even slight or non-visible amounts of blood or protein found in the cerebrospinal fluid and deposited inside the valve can cause the observed malfunction.As described in our literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SHUNTASSISTANT 20
Type of Device
HYDROCEPHALUS VALVES
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8063791
MDR Text Key126926461
Report Number3004721439-2018-00273
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K103003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup
Report Date 01/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/13/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2012
Device Model NumberFV424T
Device Catalogue NumberFV424T
Device Lot Number4501157983
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/17/2018
Distributor Facility Aware Date10/30/2018
Device Age11 YR
Date Manufacturer Received10/30/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age11 YR
Patient Weight23
-
-